搜尋結果
US drug industry middlemen defend business model amid accusations of raising patient costs
Reuters· 2 日前U.S. pharmaceutical industry middlemen defended their role in the healthcare system during a .. ...
Should You Pick Roche Stock Around $40 After Positive Data For Its Obesity Drugs?
Forbes· 5 日前The stock price of Roche (OTCMKTS: RHHBY) is up 10% in a week, compared to around ...
Growth Portfolio Will Likely Drive Bristol Myers Squibb's Q2
Forbes· 2 日前The company should benefit from continued market share gains for its growth portfolio ... ...
Two Dozen Patients Are Worth Billions in Pharma’s Hottest Market
Bloomberg· 4 日前The 25 people in Roche Holding AG’s obesity pill study would barely be enough to field both ...
Cheap Ozempic Copycats Are Suddenly Everywhere. Are They Safe?
Bloomberg· 3 日前Cheap Ozempic Copycats Are Suddenly Everywhere. Listen to the Big Take podcast to find out why ...
Meet America’s Best Employers For Women 2024
Forbes· 4 日前For Anne Roemer, a mother of twins and NASA’s deputy human capital officer, that juggle is ...
Pfizer's gene therapy for rare genetic bleeding disorder succeeds in late-stage trial
CNBC· 2 日前The treatment for hemophilia A could become the company's second ...
U.K. Approves Wegovy Weight-Loss Drug For Heart Problems
Forbes· 3 日前British regulators have approved anti-obesity drug Wegovy to prevent serious cardiovascular ...
Wall St ends volatile session lower in aftermath of global tech outage
Reuters· 7 日前U.S. stocks extended their slump on Friday as lingering chaos related to a global ...
Viking Therapeutics stock jumps nearly 30% after drugmaker moves weight loss injection to ...
CNBC· 1 日前Shares of Viking Therapeutics jumped 28% on Thursday after the biotech company < ...